Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study.

ABSTRACT:

Background

The availability of pharmacogenomic (PGx) methods to determine the right drug and dosage for individualized patient treatment has increased over the past decade. Adoption of the resulting PGx reports in a clinical setting and monitoring of clinical outcomes is a challenging and long-term commitment.

Objective

This study summarizes an extended PGx deep sequencing panel intended for medication dosing and prescription guidance newly adopted in a pain management clinic. The primary outcome of this retrospective study reports the number of cases and types of drugs covered, for which PGx data appears to have assisted in optimal drug prescription and dosing.

Methods

A PGx panel is described, encompassing 23 genes and 141 single-nucleotide polymorphisms or indels,

SUBMITTER: Tagwerker C 

PROVIDER: S-EPMC10414297 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature